Literature DB >> 31006896

Oral intramuscular hemangioma: Report of three cases.

Carlos M Lescura1, Bruno A B de Andrade2, Kelly T Bezerra2, Michelle Agostini2, Milagros V A Ankha1, Felix de Castro3, Yasmin R Carvalho1, Mário J Romañach2, Ana Lia Anbinder1.   

Abstract

Intramuscular hemangioma (IMH) represents less than 1% of all hemangiomas. In the head and neck region, it occurs mostly in the masseter, temporalis and sternocleidomastoid muscles. Despite its infiltrative growth pattern and several worrisome histological features, such as increased mitotic activity, plumpness of the nuclei, intraluminal papillary projections or perineural infiltration, the lesion is benign, and complete surgical excision is the preferred treatment for such oral lesions. Herein, we report three rare cases of IMH in the tongue and lip, discuss the clinical and histological aspects, and review the literature regarding this lesion.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  intramuscular hemangioma; vascular malformations; vascular tumors

Mesh:

Year:  2019        PMID: 31006896     DOI: 10.1111/cup.13482

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  4 in total

1.  Intramuscular hemangioma in the zygomaticus minor muscle: a case report and literature review.

Authors:  Sung Jae Wee; Myong Chul Park; Chan Min Chung; Seung Wan Tak
Journal:  Arch Craniofac Surg       Date:  2021-04-20

2.  Intramuscular Hemangioma of Masseter Muscle: Case Report of Rare Clinical Entity.

Authors:  Ramanpal Singh Makkad; Gunjan Agarwal; Santosh Gupta; Ravleen Nagi; Akshay Ragit; Farhin Jamal
Journal:  Ann Maxillofac Surg       Date:  2021-07-24

3.  Imaging Findings From Different Pathological Types of Oral and Maxillofacial Intramuscular Hemangiomas for Selecting Optimum Management.

Authors:  Dan Zhu; Xiaoqing Dai; Jingbo Wang; Chunye Zhang; Xiaofeng Tao; Lizhong Wu; Ling Zhu
Journal:  Front Oncol       Date:  2022-01-31       Impact factor: 6.244

Review 4.  Gangliosides as Biomarkers of Human Brain Diseases: Trends in Discovery and Characterization by High-Performance Mass Spectrometry.

Authors:  Mirela Sarbu; Raluca Ica; Alina D Zamfir
Journal:  Int J Mol Sci       Date:  2022-01-08       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.